Wenxin Li

发表

FastMM: an efficient toolbox for personalized constraint-based metabolic modeling

Wenzhong Xiao, Gong-Hua Li, Shaoxing Dai, 2020, BMC Bioinformatics.

Toxin acidic residue evolutionary function-guided design of de novo peptide drugs for the immunotherapeutic target, the Kv1.3 channel

Fan Yang, Jing Hong, Yingliang Wu, 2015, Scientific Reports.

Mucroporin-M1 Inhibits Hepatitis B Virus Replication by Activating the Mitogen-activated Protein Kinase (MAPK) Pathway and Down-regulating HNF4α in Vitro and in Vivo*

Yingliang Wu, Xiaohui Tian, Wenxin Li, 2012, The Journal of Biological Chemistry.

Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus

Yingliang Wu, Wenxin Li, Zhenhuan Zhao, 2013, Biomaterials.

Anti-HIV-1 Activity of a New Scorpion Venom Peptide Derivative Kn2-7

Fang Liu, Yan Zhang, Wenxin Li, 2012, PloS one.

Improved fusion protein expression of EGFP via the mutation of both Kozak and the initial ATG codon

Dahe Jiang, Yingliang Wu, Wenxin Li, 2007, Cellular & Molecular Biology Letters.

ImKTx1, a new Kv1.3 channel blocker with a unique primary structure

Yingliang Wu, Wenxin Li, Yingliang Wu, 2011, Journal of biochemical and molecular toxicology.

Molecular basis of inhibitory peptide maurotoxin recognizing Kv1.2 channel explored by ZDOCK and molecular dynamic simulations

Su Qiu, Yingliang Wu, Wenxin Li, 2008, Proteins.

Molecular basis for the toxin insensitivity of scorpion voltage-gated potassium channel MmKv1.

Jing Chen, Yingliang Wu, Wenxin Li, 2016, The Biochemical journal.

Interaction simulation of hERG K+ channel with its specific BeKm-1 peptide: insights into the selectivity of molecular recognition.

Yingliang Wu, Wenxin Li, Chao Dai, 2007, Journal of proteome research.